We are live on
!
Find out more
FA
Fountainhead AM Portfolio holdings
AUM
$111M
1-Year Est. Return
16.78%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+16.78%
3 Year Est. Return
+49.99%
5 Year Est. Return
+48.25%
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$27.4M
(+17%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
9.4%
Top 10 Holdings %
Top 10 Hldgs %
77%
Holding
63
New
10
Increased
30
Reduced
17
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PGIM Ultra Short Bond ETF
PULS
|
+$2.74M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.25M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.2M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.17M |
| 5 |
Vanguard Large-Cap ETF
VV
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.49M |
| 2 |
Apple
AAPL
|
+$1.36M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$204K |
| 4 |
iShares Short Maturity Bond ETF
NEAR
|
+$190K |
| 5 |
Meta Platforms (Facebook)
META
|
+$170K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.42% |
| 2 | Technology | 3.74% |
| 3 | Consumer Discretionary | 2.65% |
| 4 | Communication Services | 1.55% |
| 5 | Financials | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Netflix
NFLX
$292B
| $237K | 0.13% |
4,540
-820
| -15% | -$43.5K |
|
52
Invesco QQQ Trust
QQQ
$455B
| $237K | 0.13% |
743
+41
| +6% | +$13.1K |
|
53
Alibaba
BABA
$269B
| $232K | 0.12% |
1,025
+16
| +2% | +$3.93K |
|
54
ARK Innovation ETF
ARKK
$5.89B
| $228K | 0.12% |
1,900
+228
| +14% | +$30.9K |
|
55
Mastercard
MA
$477B
| $221K | 0.12% |
+622
| New | +$217K |
|
56
VanEck Green Bond ETF
GRNB
$182M
| $218K | 0.12% |
8,062
| – | – |
|
57
Schwab US Dividend Equity ETF
SCHD
$102B
| $203K | 0.11% |
+8,355
| New | +$190K |
|
58
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $201K | 0.11% |
+4,085
| New | +$200K |
|
59
VirnetX Holding Corp
VHC
$52.3M
| $58K | 0.03% |
525
-510
| -49% | -$63.9K |
|
|
ARKOW
60
DELISTED
ARKO Corp Warrant
ARKOW
| $31K | 0.02% |
+15,000
| New | +$26.5K |
|
|
61
Neurocrine Biosciences
NBIX
$17.7B
| – | – |
-2,124
| Closed | -$204K |
|
|
62
Oracle
ORCL
$331B
| – | – |
-23,086
| Closed | -$1.49M |
|
|
BMY.RT
63
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-29,928
| Closed | -$21K |
|
Similar funds
EGP
WWMP
VPW
HCM
NIM
LP
FCU
OCA
Fountainhead AM's Q1 2021 Portfolio in Review
As of Q1 2021, Fountainhead AM held 63 positions worth $188M, up 17% from $161M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Fountainhead AM deployed $17.7M of net new capital in Q1 2021, opening 10 new positions and adding to 30 existing holdings. Its largest new stake was PGIM Ultra Short Bond ETF: 55,004 shares worth $2.74M.
By sector, the portfolio is most concentrated in Healthcare at 4.4% of assets, up from 3% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $1.36M trimmed.
- Fountainhead AM's largest Q1 2021 buy was PGIM Ultra Short Bond ETF: 55,004 shares worth $2.74M.
- Fountainhead AM added most to iShares Core US Aggregate Bond ETF in Q1 2021, an estimated $2.25M increase.
- Fountainhead AM's biggest Q1 2021 reduction was Apple, cutting an estimated $1.36M.
- Fountainhead AM fully exited Oracle in Q1 2021, selling an estimated $1.49M.
- Fountainhead AM's ten largest holdings make up 77% of its $188M portfolio in Q1 2021.
- Fountainhead AM opened 10 new positions and closed 3 in Q1 2021.
- Fountainhead AM's portfolio value rose 17% quarter-over-quarter to $188M.
Based on Fountainhead AM's 13F filing for Q1 2021, filed 6 May 2021.